Abe Masaki | Department Of Clinical Pharmacology Kyoto Pharmaceutical University
スポンサーリンク
概要
関連著者
-
Matsubara Hiroaki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Katamura Maki
AMI-Kyoto Multi-Center Risk Study Group
-
Hayashi Hironori
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Nakamura T
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Kobara Miyuki
Department of Cardiology, Kyoto Prefectural University School of Medicine
-
Katamura Maki
Department Of Cardiology Kyoto Second Red Cross Hospital
-
Matsubara Hiroaki
Department Of Cardiology Kyoto Prefectural University Of Medicine
-
Nakata Tetsuo
Department Of Cardiovascular Medicine Nantan General Hospital
-
ABE Masaki
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
TOBA Hiroe
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Toba Hiroe
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Abe Masaki
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Kobara Miyuki
Departments Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Kobara Miyuki
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Kobara Miyuki
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Abe Masaki
Department Of Agricultural Chemistry The University Of Tokyo
-
Kimata Masaki
Department Of Cardiology Kyoto First Red Cross Hospital
-
Nakata Tetsuo
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Kobara Miyuki
Department Of Cardiology Kyoto First Red Cross Hospital
-
Nakata Tesuo
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Nakata Tetsuo
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Hayashi Hironori
Department Of Breast Oncology Aichi Cancer Center Hospital
-
Matsubara Hiroaki
Department Of Bioscience National Cardiovascular Center Research Institute
-
Tanaka Nana
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
TATSUMI Tetsuya
Department of Cardiovascular Medicine, Nantan General Hospital
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Nantan General Hospital
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Tatsumi Tetsuya
Department Of Cardiology Nantan General Hospital
-
Tatsumi T
First Department Of Medicine Nara Medical University
-
Tatsumi Tetsuya
Department of Cardiology and Vascular Regenerative Medicine, Kyoto Prefectural University School of Medicine
-
GOUDA Eri
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Tatsumi T
Kyoto Prefectural University Of Medicine
-
Gouda Eri
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Nakae Takeshi
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
YAMADA Hiroyuki
Department of Materials Engineering, Graduate school of Engineering, The University of Tokyo
-
Yamada Hiroyuki
Ami-kyoto Multi-center Risk Study Group
-
Tatsumi Tetsuya
Kyoto Prefectural University Of Medicine
-
Makino H
Department Of Medicine And Clinical Science Okayama University Graduate School Of Medicine And Denti
-
Yokoi Hirokazu
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Tatsumi Tetsuya
京都第一赤十字病院 循環器科
-
Tanaka Kenta
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Furumori Akiko
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Ohigashi Makoto
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Uchida Yuugo
Department of Clinical Pharmacology, Division of Pathological science, Kyoto Pharmaceutical Universi
-
Tamura Kazuya
Department of Clinical Pharmacology, Kyoto Phamaceutical University
-
Uchida Yuugo
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Matsuoka H
Kyoto Univ. Kyoto
-
Tsutsumi Takeshi
First Department Of Medicine Nara Medical University
-
Tatsumi Tetsuya
First Department Of Internal Medicine Nara Medical University
-
Yamada Hiroyuki
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Nomura Tetsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Tanaka Kenta
Department Of Applied Chemistry School Of Engineering Osaka City University
-
Tamura Kazuya
Department Of Clinical Pharmacology Kyoto Phamaceutical University
-
Furumori Akiko
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Matsubara Hiroaki
Division Of Cardiology And Nephrology Department Of Medicine Kyoto Prefectural University Of Medicin
-
Yokoyama Hitoshi
Division Of Nephrology Kanazwa Medical University
-
Ohigashi Makoto
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Nakamura Takeshi
Kyoto Prefectural University Of Medicine Department Of Cardiology
-
Miyoshi Hironori
Cardiovascular Division Department Of Medicine Ii Kansai Medical University
-
Hirata Yoshihide
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Yamada Hiroyuki
Department Of Anatomy School Of Dentistry Aichi-gakuin University
-
Tanaka Kenta
Department of Applied and Bioapplied Chemistry, Graduate School of Engineering, Osaka City University
著作論文
- Aldosterone Nongenomically Produces NADPH Oxidase-Dependent Reactive Oxygen Species and Induces Myocyte Apoptosis
- PJ-112 Aldosterone Activates Apoptosis Signal-Regulating Kinase 1 (ASK-1) through Nongenomical ROS production and Induces Myocyte Apoptosis.(Heart failure, basic(05)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulatio
- PJ-764 Aldosterone Directly Induces Myocyte Apoptosis through NADPH Oxidase-Derived Reactive Oxygen Species(Development and differentiation-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-401 Aldosterone Rapidly Activates MEK-ERK1/2 Signaling Pathway via Membrane Bound Mineralocorticoid Receptor(Heart failure, basic-5 (M) PJ68,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)